Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Everolimus

Lymphoedema with subsequent progression to elephantiasis nostras verrucosa

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Picone V, et al. Elephantiasis nostras verrucosa induced by everolimus. Italian Journal of Dermatology and Venereology 158: 422-423, No. 5, Oct 2023. Available from: URL: https://dx.doi.org/10.23736/S2784-8671.23.07528-X Picone V, et al. Elephantiasis nostras verrucosa induced by everolimus. Italian Journal of Dermatology and Venereology 158: 422-423, No. 5, Oct 2023. Available from: URL: https://​dx.​doi.​org/​10.​23736/​S2784-8671.​23.​07528-X
Metadaten
Titel
Everolimus
Lymphoedema with subsequent progression to elephantiasis nostras verrucosa
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-56842-1

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Thiamazole

Case report

Baricitinib

Case report

Antineoplastics

Case report

Propranolol

Case report

Antineoplastics